Managed Healthcare Executive July 14, 2021
Briana Contreras

International Generic and Biosimilar Medicines Association recently released the report, “A Vision for the Global Generic and Biosimilar Medicines Industry,” covering the current global Generic and Biosimilar medicine industry, and released a vision of what the market will be in 2030 and how to achieve it.

The International Generic and Biosimilar Medicines Association (IGBA) recently released a report which takes a look at the current global Generic and Biosimilar medicine industry, and released a vision of what the market will be in 2030.

The report, “A Vision for the Global Generic and Biosimilar Medicines Industry,” covers the contribution of the pharmaceutical sector to global health outcomes and economies, the opportunities, challenges and disruptions for the industry, as well as its...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
STAT+: After AI protein folding, David Baker’s lab identifies millions of smaller drug candidates
Fierce Biotech Layoff Tracker 2024: BMS to cut 2K+ roles; Tessera trims workforce in shift to clinic
What Do Weight-Loss Drugs Mean for Diet Industry Built on Eating Less and Exercise?
Podcast #1: Doing Digital Deals in Life Sciences | Corporate Culture
BMS plans $1.5B in cuts through '25, with 2000-plus layoffs

Share This Article